A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Sponsored by Eli Lilly and Company
About this study
The purpose of this pediatric, chronic weight management, Phase 3 Master Protocol (PWMP) is to create a framework to evaluate the safety and efficacy of pharmacologic agents for the treatment of obesity or overweight in pediatric participants.
The PWMP establishes entry criteria for newly enrolled participants across the master and the ISAs. The ISAs may start independently of other ISAs as interventions become available for clinical testing. PWMP results will be reported when all the ISA's complete.
Where this study is enrolling (18)
- I'm interested
University of Arizona
Tucson, Arizona
- Call 805-483-1185 x.947
Carey Chronis MD Pediatric, Infant and Adolescent Medicine
Oxnard, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 727-544-4842
Stamford Therapeutics Consortium
Stamford, Connecticut
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call ania.jastreboff@yale.edu
Yale School of Medicine - Yale Diabetes Center (YDC)) Trials
New Haven, Connecticut
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 404-256-2593
Children's Healthcare of Atlanta - Center for Advanced Pediatrics
Atlanta, Georgia
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Show all 18 locations
- I'm interested
Ann and Robert Lurie Children's Hospital of Chicago
Chicago, Illinois
- Call 337-519-4742
Velocity Clinical Research
Lafayette, Louisiana
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 228-206-1283
Dynamed Clinical Research, LP d/b/a DM Clinical Research
Gulfport, Mississippi
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 314-567-3377
Sundance Clinical Research
St Louis, Missouri
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 402-933-6500
Velocity Clinical Research
Omaha, Nebraska
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 252-222-5700
Lucas Research, Inc
Morehead City, North Carolina
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 412-692-6935
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 615-322-6000
Vanderbilt Health One Hundred Oaks
Nashville, Tennessee
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 713-981-6002
La Providence Pediatrics Clinic - Chemidox Clinical Trials
Houston, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 281-517-0550
Martin Diagnostic Clinic
Tomball, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 713-500-5010
McGovern Medical School
Houston, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Dynamed Clinical Research, LP d/b/a DM Clinical Research
Houston, Texas
- Call 801-542-8190
Velocity Clinical Research, Salt Lake City
West Jordan, Utah
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Who can participate
Inclusion criteria
- ✓Have a history of at least 1 unsuccessful effort to lose sufficient body weight after participation in a structured lifestyle modification program (diet and exercise counseling for at least 3 months) prior to screening.
- ✓Obesity as defined by BMI equal to or above the 95th percentile for age and sex (on age- and gender-specific growth chart \[CDC-NCHS, 2022\]); OR
- ✓Applies to participant age between 12 and \<18 years old. Overweight as defined by BMI equal to or above the 85th percentile but less than the 95th percentile for age and sex, on age- and sex-specific growth chart (CDC-NCHS, 2022), and at least 1 weight-related comorbidity,
- ✓hypertension
- ✓type 2 diabetes (T2D)
- ✓prediabetes
- ✓dyslipidemia
- ✓obstructive sleep apnea
- ✓metabolic dysfunction-associated steatohepatitis (MASH) or metabolic dysfunction-associated steatotic liver disease (MASLD)
Exclusion criteria
- ✕Have undergone or plan to undergo weight reduction procedure during the study, such as, but not limited to:
- ✕gastric bypass
- ✕sleeve gastrectomy
- ✕restrictive bariatric surgery, such as Lap-Band® gastric banding, or
- ✕any other procedure intended to result in weight reduction.
- ✕Have a diagnosis that is a secondary cause of obesity or have a history of abrupt onset of obesity suggesting a secondary cause, such as hypothalamic, monogenetic, syndromic, or endocrine causes.
- ✕Have a self-reported, or by parent or legal guardian where applicable, decrease in body weight greater than 5 kg (11 lbs) within 90 days before screening irrespective of medical records
- ✕Have type 1 diabetes or history of ketoacidosis, or hyperosmolar state.
- ✕Have HbA1c \>9.0% (75 mmol/mol) as measured by central laboratory at screening.
- ✕Have a family or personal history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia Syndrome Type 2.
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.